Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2021 Jan 12;30(3):105595. doi: 10.1016/j.jstrokecerebrovasdis.2020.105595

Figure 4. Glibenclamide reduces hemorrhagic transformation in cohort 2.

Figure 4.

(A) The severity of HT was less in animals treated with glibenclamide (white bars) compared to placebo treated animals (gray bars; p<0.01). (B) The neurological scores are also worse in animals with increasing HT severity (p=0.01)